Identification of C‐terminal Hsp70‐interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation

• Published in: Journal of cellular and molecular medicine 2015-08, Vol.19 (8), p.1814-1824
• Main Authors: Xie, Jianmin, Gu, Jieruo
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Animals; Arthritis; Assaying; Bone Morphogenetic Proteins - metabolism; Calcification, Physiologic - drug effects; Cartilage; Cell Differentiation - drug effects; CHIP; Chronic exposure; Cytokines; Degradation; HEK293 Cells; Hsc70 protein; Hsp70 protein; Humans; Immunoprecipitation; Inflammation; Inflammatory diseases; Joint diseases; Kinases; Lysine - metabolism; Mice; Mineralization; Molecular modelling; Molecular Sequence Data; Necrosis; Original; osteoblast; Osteoblastogenesis; Osteoblasts; Osteoblasts - cytology; Osteoblasts - drug effects; Osteoblasts - metabolism; Osteopenia; Osteoporosis; osterix; Plasmids; Protein Binding - drug effects; Proteins; Proteolysis - drug effects; Real-Time Polymerase Chain Reaction; Residues; Signal Transduction - drug effects; siRNA; Sp7 Transcription Factor; TNF‐α; Transcription factors; Transcription Factors - chemistry; Transcription Factors - metabolism; Transfection; Tumor necrosis factor; Tumor Necrosis Factor-alpha - pharmacology; Tumor necrosis factor-TNF; Tumors; Ubiquitin; Ubiquitin - metabolism; Ubiquitin-protein ligase; Ubiquitin-Protein Ligases - metabolism; Ubiquitination; Ubiquitination - drug effects
• ISSN: 1582-1838; 1582-4934
• DOI: 10.1111/jcmm.12553

In patients with inflammatory arthritis, tumour necrosis factor (TNF)‐α are overproduced in inflamed joints. This leads to local erosion of cartilage and bone, periarticular osteopenia, as well as osteoporosis. But less is known regarding the molecular mechanisms that mediate the effect of TNF‐α on osteoblast function. The purpose of this study was to test that C terminus of Hsc70‐interacting protein (CHIP) has a specific role in suppressing the osteogenic activity of osteoblasts under inflammatory conditions. C2C12, MC3T3‐E1 and HEK293T cell lines were cultured and cotransfected with related plasmids. After transfection, the cells were cultured further in the presence or absence of murine TNF‐α and subjected to real time RT‐PCR, Western blot, Ubiquitination assay, Co‐immunoprecipitation, Luciferase reporter assay, Small interfering RNAs and Mineralization assay. The expression levels of TNF‐α‐induced CHIP and Osx were examined by RT‐PCR and Western blot analysis. Co‐immunoprecipitation and ubiquitination assays revealed ubiquitinated Osx, confirmed that CHIP indeed interacted with Osx and identified K55 and K386 residues as the ubiquitination sites in Osx, Luciferase reporter assay and Small interfering RNAs examined whether TNF‐α target the bone morphogenetic protein signalling through CHIP. We established stable cell lines with the overexpression of HA‐CHIP, Mineralization assay and CHIP siRNA demonstrated the important roles of CHIP on osteoblast function in conditions in which TNF‐α is overexpressed. We found that the K55 and K386 residues are ubiquitination site(s) in Osx, and that TNF‐α inhibits osteoblast differentiation by promoting Osx degradation through up‐regulation of E3 ubiquitin ligase CHIP in osteoblast. Thus, CHIP targets Osx for ubiquitination and degradation in osteoblasts after chronic exposure to TNF‐α, and inhibition of CHIP expression in osteoblasts may be a new mechanism to limit inflammation‐mediated osteoporosis by promoting their differentiation into osteoblasts.